ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Esperion Therapeutics, Inc. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 20.08% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -2.53
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 186.36%, its profits have fallen by -815.5%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Esperion Therapeutics, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Esperion Therapeutics, Inc.
186.36%
0.09
93.06%
S&P 500
25.41%
1.92
13.25%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
12.12%
EBIT Growth (5y)
20.08%
EBIT to Interest (avg)
-2.53
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.12
Sales to Capital Employed (avg)
1.47
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
86.16%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-2.35
EV to EBIT
18.06
EV to EBITDA
18.04
EV to Capital Employed
14.04
EV to Sales
2.70
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
77.74%
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend22What is working for the Company
NET SALES(HY)
At USD 248.55 MM has Grown at 85.34%
OPERATING CASH FLOW(Y)
Highest at USD -10.69 MM
NET PROFIT(HY)
Higher at USD 36.64 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -125.89 %
RAW MATERIAL COST(Y)
Fallen by -10.62% (YoY
-11What is not working for the Company
NET SALES(Q)
At USD 80.1 MM has Fallen at -20.52%
PRE-TAX PROFIT(Q)
At USD -25.2 MM has Fallen at -383.59%
NET PROFIT(Q)
At USD -25.2 MM has Fallen at -344.33%
INTEREST(9M)
At USD 64.48 MM has Grown at 26.6%
Here's what is working for Esperion Therapeutics, Inc.
Debt-Equity Ratio
Lowest at -125.89 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Operating Cash Flow
Highest at USD -10.69 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Raw Material Cost
Fallen by -10.62% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Esperion Therapeutics, Inc.
Net Sales
At USD 80.1 MM has Fallen at -20.52%
over average net sales of the previous four periods of USD 100.78 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Pre-Tax Profit
At USD -25.2 MM has Fallen at -383.59%
over average net sales of the previous four periods of USD -5.21 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -25.2 MM has Fallen at -344.33%
over average net sales of the previous four periods of USD -5.67 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Interest
At USD 64.48 MM has Grown at 26.6%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
